Table 1. Patient characteristics and... | American Society of Hematology

Table 1.

Patient characteristics and incidence of late-onset neutropenia

Characteristics	DA-EPOCH nos. (%)	DA-EPOCH-R nos. (%)	P₂
Total patients	54	76
Sex, male	33 (61)	50 (66)	NS
Age, median	44	49	NS
Stage III or IV	36 (67)	54 (71)	NS
PS higher than 1	7 (13)	12 (16)	NS
LDH higher than normal	34 (63)	35 (46)	.06*
LON by histology
DLBCL	0/35 (0)	2/44 (5)	NA
ARL	0/19 (0)	2/8 (25)	NA
MCL	0/0	2/24 (8)	NA
Total LON incidence	0/54 (0)	6/76 (7.9)	.04†

Characteristics	DA-EPOCH nos. (%)	DA-EPOCH-R nos. (%)	P₂
Total patients	54	76
Sex, male	33 (61)	50 (66)	NS
Age, median	44	49	NS
Stage III or IV	36 (67)	54 (71)	NS
PS higher than 1	7 (13)	12 (16)	NS
LDH higher than normal	34 (63)	35 (46)	.06*
LON by histology
DLBCL	0/35 (0)	2/44 (5)	NA
ARL	0/19 (0)	2/8 (25)	NA
MCL	0/0	2/24 (8)	NA
Total LON incidence	0/54 (0)	6/76 (7.9)	.04†

NS indicates not significant; PS, performance score; LDH, lactate dehydrogenase; DLBCL, diffuse large B-cell lymphoma; ARL, AIDS-related lymphoma; MCL, mantle cell lymphoma; and NA, not applicable.

Chi-squared.

†

Two-sided Fisher exact t-test.

View Large

This Feature Is Available To Subscribers Only